Intelligent Bio Solutions Cash Flow Statement (2020-2024) | INBS

Cash Flow Statement Sep2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024
Operating Activities
Net Income -1.08M-3.14M-0.85M-1.44M-1.34M-2.08M-2.13M-6.35M-2.70M-2.56M-2.02M-2.99M
Depreciation and Depletion 0.01M0.02M
Gains from Investment Securities -0.36M0.03M0.00M0.00M
Asset Writedowns and Impairment 0.02M0.00M0.07M0.00M263.00
Cash from Operations -2.68M-1.68M0.08M-1.43M-0.29M-1.72M-1.89M-2.38M-2.52M-0.58M-1.31M-2.87M-2.45M
Depreciation, Depletion & Amortization
Amortization of Goodwill 4.10M0.06M
Amortizatization of Intangibles 0.05M0.06M0.06M0.06M0.06M
Depreciation & Amortization (CF) 0.35M0.11M0.25M0.23M0.27M
Change in Working Capital
Change in Receivables -1.83M-0.01M-0.00M0.27M-0.30M0.10M
Change in Inventory 0.04M0.27M0.05M-0.02M-0.13M
Change in Account Payables -1.44M-0.02M-0.64M-0.36M0.48M0.77M-0.01M-1.22M0.30M1.02M1.22M-1.85M0.15M
Change in Accured Expenses 0.01M-0.03M0.00M0.00M-37.000.00M0.00M-0.22M
Other Working Capital Changes 0.02M0.18M-0.24M-0.02M0.12M0.48M0.21M-0.29M0.27M-0.07M-0.14M-0.08M0.06M
Investing Activities
Capital Expenditures -0.00M
Acquisitions 0.36M0.18M
Cash from Investing Activities -0.70M-0.47M-0.21M0.17M-0.18M0.00M
Financing Activities
Other financing activities -0.04M0.05M
Cash from Financing Activities 3.29M1.72M0.05M10.77M
Additional items
Exchange Rate Effect -0.05M-0.01M-0.05M0.01M0.03M-0.09M-0.13M0.09M-0.00M-0.02M-0.04M0.07M-0.05M
Change in Cash 0.57M-1.69M0.03M-1.42M-0.43M-2.52M-2.50M-2.83M-0.63M-0.74M-1.35M0.93M8.28M
Free Cash Flow -2.68M-1.68M0.08M-1.43M-0.29M-1.72M-1.89M-2.38M-2.52M-0.58M-1.31M-2.87M-2.44M
Net Cash Flow 0.62M-1.68M0.08M-1.43M-0.29M-2.43M-2.37M-2.59M-0.63M-0.72M-1.31M-2.87M8.33M